Evaluation of safety and immunogenicity of the Td vaccine in laboratory studies

Rymkiewicz, D.; Sawicki, J.; Wysokińska, T.

Przeglad Epidemiologiczny 46(4): 325-327

1992


ISSN/ISBN: 0033-2100
PMID: 1305784
Document Number: 396339
The new vaccine recommended as the booster dose contains in 0.5 ml: 10 BU Te-toxoid, 2 Lf Di-toxoid, 4.5-0.5 mg Al and 0.01% merthiolate. In 7 consecutive series it was state, the vaccine was safety and stable. The potency was 40-50 JO for Te and 30-40 for Di. The last series was recommended for vaccination under clinical control.

Document emailed within 1 workday
Secure & encrypted payments